InvestorsHub Logo

jerseyshore

03/21/07 2:24 PM

#24 RE: jerseyshore #23

In the biotechnology field, Chris and James Hengst, President & CEO, purchased
Cellular Products Inc. and formed ZeptoMetrix in July 1999 followed by the April 2004 purchase of Impath BioClinical
Partners located in Franklin, MA. In addition to ZeptoMetrix, Chris and Jim formed Buckler Biodefense Corporation in 2006 in partnership with Virionyx, Ltd., located in Auckland, New Zealand http://www.zeptometrix.com/zeptogramwinter07.pdf